CVAC
CureVac N.V. Ordinary Shares (CVAC)
$87
About CureVac N.V. Ordinary Shares (CVAC)
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Details
Daily high
$3.02
Daily low
$2.83
Price at open
$2.86
52 Week High
$5.28
52 Week Low
$2.22
Market cap
643.8M
Dividend yield
0.00%
Volume
820,936
Avg. volume
587,335
P/E ratio
5.22
CureVac N.V. Ordinary Shares News
Details
Daily high
$3.02
Daily low
$2.83
Price at open
$2.86
52 Week High
$5.28
52 Week Low
$2.22
Market cap
643.8M
Dividend yield
0.00%
Volume
820,936
Avg. volume
587,335
P/E ratio
5.22